Prostatic stromal sarcoma with neuroectodermal differentiation

Abstract

Prostatic stromal sarcoma is a fairly rare tumor that constitutes approximately 0.1–0.2% of all prostatic cancers. Detailed characteristics of the tumor are still unclear due to its rarity.We describe a case of prostatic stromal sarcoma in a 63 year-old man who suffered from urinary obstructive symptoms. Palliative transuterine resection was performed and the preliminary histopathological diagnosis was neuroendocrine carcinoma. After chemotherapy, total pelvic exenteration was performed. Histopathologically, the tumor was composed of monotonously proliferating small to medium-sized round cells, which existed in compact islands with loose or dense fibrovascular networks. Immunohistochemically, the tumor cells were widely positive for vimentin, CD56, CD99 and focally positive for synaptophysin, CD10, progesterone receptor, desmin and CD34, but negative for EMA, cytokeratin, estrogen receptor, S-100 and myoglobin. Most of the previously reported tumors exhibited positive stainability for CD10 and progesterone receptor. In addition to these markers, expressions of CD56, CD99 and synaptophysin were characteristically detected in our case. To the best of our knowledge, we present the first case of prostatic stromal sarcoma with characteristic immunohistochemical staining properties. Although the biological characteristics of this rare tumor have not yet been elucidated, these findings suggest prostatic stromal sarcoma can potentially show neuroectodermal differentiation.Virtual slideThe virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/7291874028051262

An extraordinary T/NK lymphoma, nasal type, occurring primarily in the prostate gland with unusual CD30 positivity: case report and review of the literature

“…Immunohistochemical results show expression of epithelial markers such as CK, CK8/18 and PSA et al, rather than lymphocyte ones. Another rare tumor, prostatic stromal sarcoma, is often showed pervasive small and medium-sized round cells around the residual glands too [20]. It is suspiciously derived from mesenchymal pluripotent stem cells in the prostatic stroma and usually express CD10, CD34 and PR.…”

A Review of the Literature on Primary Leiomyosarcoma of the Prostate Gland

“… Some PLSOPs mimic stromal sarcoma of the prostate and sarcomatoid carcinoma of the prostate. Macroscopic examination of stromal sarcoma of the prostate specimen may reveal a whitish-yellow multinodular appearance with focal necrosis; microscopic examination of the specimen may show sarcomatoid oval to spindle cells; immunohistochemical staining of the specimen tends to show the membrane of the tumour cells to be positive with CD56, focal positivity in the cytoplasm of the tumour cells for synaptophysin, and positive staining on the cell membrane of the tumour cells for CD99 [ 23 ]. Microscopic examination of sarcomatoid carcinoma of the prostate gland (carcinosarcoma of the prostate) tends to reveal a biphasic tumour with adenocarcinoma and recognizable sarcoma components including chondrosarcoma, rhabdomyosarcoma, angiosarcoma, osteosarcoma, and leiomyosarcoma [ 24 ].…”

Treatment of prostatic stromal sarcoma with robot-assisted laparoscopic radical prostatectomy in a young adult: A case report

“…PSS is an extremely rare subtype of prostate sarcoma with <30 documented cases (2,3,5,6). The majority of these lesions present in the sixth and seventh decades of life, and the majority of patients present with symptoms of urethral obstruction, such as in the present case (2,3,5,6). Patients with PSS usually have a PSA level within the normal range.…”